# EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)

> **NCT02027870** · — · COMPLETED · sponsor: **JW Medical Systems Ltd** · enrollment: 625 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** EXCEL-II biodegradable polymer sirolimus-eluting stent

## Key facts

- **NCT ID:** NCT02027870
- **Lead sponsor:** JW Medical Systems Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-08
- **Primary completion:** 2017-07-30
- **Final completion:** 2019-11-07
- **Target enrollment:** 625 (ACTUAL)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02027870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02027870, "EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02027870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*